Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification

Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification

We evaluated the prognostic efficiency of the European Leukemia Net (ELN) 2017 criteria on the post-transplant outcomes of 174 patients with intermediate (INT; <i>n</i> = 108, 62%) or adverse (ADV) risk (<i>n</i> = 66, 38%) of acute myeloid leukemia; these patients had receiv...

Full description

Bibliographic Details
Main Authors: Tong-Yoon Kim, Silvia Park, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung-Soo Park, Young-Woo Jeon, Seung-Hawn Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
acute myeloid leukemia
allogeneic transplantation
ELN 2017 risk classification
prognosis
Online Access:https://www.mdpi.com/2072-6694/14/13/3199

Internet

https://www.mdpi.com/2072-6694/14/13/3199

Similar Items